Enpp-1-IN-28
Enpp-1-IN-28 is a ENPP1 inhibitor at the molecular and cellular levels, with IC50 values of 0.188 µM and 0.732 µM, respectively. Enpp-1-IN-28 upgrades the expression levels of IFN-β in vivo by preventing the ENPP1 from hydrolyzing the cGAMP to stimulate a more potent innate immune response. Enpp-1-IN-28 can be used for the study of metastatic breast cancer[1].
Product Specifications
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
FC1=CC2=C(C(NC(CSC3=NC4=CC(OC)=CC=C4N3)=N2)=O)C=C1
Molecular Formula
C17H13FN4O2S
Molecular Weight
356.37
References & Citations
[1]Wang X, et al. Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy. Int J Mol Sci. 2022 Jun 26;23 (13) :7104.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040630-100 1x 100 µL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741866-500 1x 500 µL
Calponin-1 (Smooth Muscle Marker) (rCNN1/832), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402550-100 1x 100 µL
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880252-500 1x 500 µL
Cytokeratin, Acidic (Type I or LMW) (Epithelial Marker) (AE-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 